TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34045081

Group type: EXPERIMENTAL
Intervention: Ceftazidime‐Avibactam (CAZ‐AVI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 0
Study: 35636516

Group type: EXPERIMENTAL
Intervention: Immediate-app group (iApp) using mobile cognitive training for 12 days (T0 to T1)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Delayed-app group (dApp) starting mobile cognitive training at T1 for 12 days (T1 to T2)
Number of subjects: 47
Study: 33715382

Group type: EXPERIMENTAL
Intervention: TR‐PH (fixed-combination tropicamide 1% and phenylephrine 2.5%)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: PH (phenylephrine 2.5%)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: TR (tropicamide 1%)
Number of subjects: 131
Study: 33020047

Group type: EXPERIMENTAL
Intervention: Transforce Transverse Appliance (TTA)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: NiTi Palatal Expander (NPE)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control Group (historical)
Number of subjects: 36
Study: 34609359

Group type: EXPERIMENTAL
Intervention: Internet-delivered pain management program with optional clinician support
Number of subjects: 659

Group type: COMPARATOR
Intervention: Control (waitlist-control group)
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: Internet-delivered pain management program
Number of subjects: 659
Study: 33097567

Group type: EXPERIMENTAL
Intervention: Olaparib and cediranib
Number of subjects: 618

Group type: COMPARATOR
Intervention: Olaparib alone
Number of subjects: 618
Study: 35553560

Group type: EXPERIMENTAL
Intervention: Heat Therapy (HT) at 39ºC for 30 min/day, 5 days/week during 3 consecutive weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Heat Therapy (HT) at 39ºC for 3 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (room temperature)
Number of subjects: 24
Study: 35027944

Group type: EXPERIMENTAL
Intervention: NMES + rTMS
Number of subjects: 240

Group type: COMPARATOR
Intervention: NMES
Number of subjects: 240

Group type: COMPARATOR
Intervention: rTMS
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control
Number of subjects: 240
Study: 32169595

Group type: EXPERIMENTAL
Intervention: Elongated containers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subsequently encountered food
Number of subjects: 0
Study: 33051727

Group type: EXPERIMENTAL
Intervention: mTICCS
Number of subjects: 30
Study: 32878869

Group type: EXPERIMENTAL
Intervention: Custom-made insole
Number of subjects: 185

Group type: COMPARATOR
Intervention: Sham insole
Number of subjects: 185

Group type: COMPARATOR
Intervention: GP-led usual care
Number of subjects: 185
Study: 35780013

Group type: EXPERIMENTAL
Intervention: Pain-related images
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Implied and actual penetrative sex images
Number of subjects: 113
Study: 32398160

Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen plus intravenous acetaminophen (NOO-A)
Number of subjects: 684

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 684
Study: 616882823

Group type: EXPERIMENTAL
Intervention: Kistinox Forte, 1 sachet per day during the first 10 days of the month for 3 months
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 150
Study: 33493450

Group type: EXPERIMENTAL
Intervention: Anakinra (200 mg twice a day on days 1-3, 100 mg twice on day 4, 100 mg once on day 5)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 116
Study: 32358638

Group type: EXPERIMENTAL
Intervention: Intermittent stimulation of the auricular branch of vagus nerve using neurostimulator V (Ducest®, Germany), starting 24 hours preoperatively and continued till the 4th postoperative day.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no stimulation).
Number of subjects: 100
Study: 36064727

Group type: EXPERIMENTAL
Intervention: TOPSY self-management intervention including a self-management support session with a pessary practitioner, a follow-up phone call 2 weeks later, and ongoing support as needed.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TOPSY self-management intervention
Number of subjects: 0
Study: 34190015

Group type: EXPERIMENTAL
Intervention: Nomogram for overall survival (OS)
Number of subjects: 7149

Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS)
Number of subjects: 7149

Group type: COMPARATOR
Intervention: Nomogram compared to TNM stage and SEER stage
Number of subjects: 7149

Group type: EXPERIMENTAL
Intervention: Calibration curves for OS and CSS
Number of subjects: 7149
Study: 32907433

Group type: EXPERIMENTAL
Intervention: Intensive glycemic control with glycemic targets of fasting blood glucose (FBG) <130 mg/dL, postprandial BG <180 mg/dL, and HbA1c <8%, using a basal-bolus insulin regimen and frequent titration of insulin.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional glucose control with prior treatment (oral antidiabetic drugs) with no titration unless meeting rescue criteria.
Number of subjects: 0
Study: 34391759

Group type: EXPERIMENTAL
Intervention: Low-dose radiation therapy (LDRT) of 0.5 Gy to bilateral whole lungs
Number of subjects: 25
Study: 34251534

Group type: EXPERIMENTAL
Intervention: Oral irrigator + toothbrush (OI group, n=15)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Oral irrigator + toothbrush (OI group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Interdental brush + toothbrush (IB group, n=15)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Toothbrush only (C group, n=15)
Number of subjects: 45
Study: 33709528

Group type: EXPERIMENTAL
Intervention: NIV and call center
Number of subjects: 20

Group type: COMPARATOR
Intervention: NIV alone
Number of subjects: 20
Study: 35552067

Group type: EXPERIMENTAL
Intervention: Resistance breathing (set at -7 cm.H2O) during LBNP
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control condition (LBNP at 3 mmHg/min)
Number of subjects: 5
Study: 36314277

Group type: COMPARATOR
Intervention: Tocilizumab
Number of subjects: 176
Study: 33827834

Group type: EXPERIMENTAL
Intervention: Active Communication Education (ACE) programme plus treatment‐as‐usual
Number of subjects: 12

Group type: COMPARATOR
Intervention: treatment‐as‐usual only (control group)
Number of subjects: 12
Study: 32546992

Group type: EXPERIMENTAL
Intervention: MKP (Met-Lys-Pro)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study: 35987195

Group type: EXPERIMENTAL
Intervention: Human-milk-based fortifiers (HMBF)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Bovine-milk-based fortifiers (BMBF)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: HMBF
Number of subjects: 119
Study: 33972379

Group type: EXPERIMENTAL
Intervention: Child-directed fast-food advertisements with premiums present
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Imagery of premiums in advertisements
Number of subjects: 28
Study: 32396917

Group type: EXPERIMENTAL
Intervention: CCBT using the Good Days Ahead program (up to 5.5 h of therapist contact)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard CBT (up to twenty 50-min sessions)
Number of subjects: 154
Study: 36465612

Group type: EXPERIMENTAL
Intervention: Cangfudaotan (CFDT) decoction
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (normal-fat diet and saline)
Number of subjects: 40

Group type: COMPARATOR
Intervention: PCOS group (high-fat diet and letrozole)
Number of subjects: 40
Study: 32168417

Group type: EXPERIMENTAL
Intervention: Ultrasound acupuncture (pulsed therapeutic ultrasound at 1 MHz for 5 minutes per point daily for 12 days)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ultrasound acupuncture
Number of subjects: 17
Study: 35446760

Group type: EXPERIMENTAL
Intervention: Gradient Diversity (GradDiv) regularizations
Number of subjects: 0
Study: 33347666

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (fraction of inspired O2 = 0.117)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Normobaric normoxia (fraction of inspired O2 = 0.21)
Number of subjects: 27
Study: 32930918

Group type: EXPERIMENTAL
Intervention: Parenting intervention
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Acculturative stress (youth's own)
Number of subjects: 532
Study: 35150943

Group type: EXPERIMENTAL
Intervention: Chitooligosaccharide (COS) 15 mg/kg
Number of subjects: 360
Study: 34011674

Group type: EXPERIMENTAL
Intervention: guselkumab
Number of subjects: 300

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 300
Study: 35218559

Group type: EXPERIMENTAL
Intervention: Terbutaline (TER; 4 mg × day-1, n = 13)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (PLA, n = 8)
Number of subjects: 21
Study: 34673918

Group type: EXPERIMENTAL
Intervention: Functional task exercise
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 145

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 145
Study: 33524284

Group type: EXPERIMENTAL
Intervention: Multidisciplinary ED-based fall prevention intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 36161487

Group type: EXPERIMENTAL
Intervention: Randomized Clinical Trial (RCT) with historical control data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard (control) treatment
Number of subjects: 0
Study: 33136253

Group type: EXPERIMENTAL
Intervention: Pharmacist-led prescribing (intervention)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional prescribing (control)
Number of subjects: 84
Study: 32348797

Group type: EXPERIMENTAL
Intervention: Energy restricted diet providing 25% (691 (42) kcal) of estimated energy requirements
Number of subjects: 14

Group type: COMPARATOR
Intervention: Energy balanced diet providing 100% (2755 (159) kcal) of estimated energy requirements
Number of subjects: 14
Study: 35763050

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Total costs of secondary care
Number of subjects: 293
Study: 33475222

Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32192905

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide and silver cations, physical separation, and compartmentalization of ICU
Number of subjects: 738
Study: 36120781

Group type: EXPERIMENTAL
Intervention: 10-mg/d Donepezil Transdermal Delivery System (TDS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5-mg/d Donepezil Transdermal Delivery System (TDS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral Donepezil (10-mg/d)
Number of subjects: 60
Study: 33970899

Group type: EXPERIMENTAL
Intervention: MRL prediction model using frame pooling for 5'UTRs of any length
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5'UTR variant of the gene HBB associated with beta‐thalassemia
Number of subjects: 0
Study: 34612846

Group type: EXPERIMENTAL
Intervention: IV tocilizumab 8 mg/kg
Number of subjects: 437

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study: 33359595

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 27
Study: 34192714

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (n=90)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Pain education (n=93)
Number of subjects: 183
Study: 35361636

Group type: EXPERIMENTAL
Intervention: Group biofeedback treatment, psycho‐education and treatment as usual (TAU)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Psycho‐education and TAU only
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Group biofeedback treatment, psycho‐education and TAU
Number of subjects: 68
Study: 34076665

Group type: EXPERIMENTAL
Intervention: Intervention group (CVD risk reduction model)
Number of subjects: 125436
Study: 32706698

Group type: EXPERIMENTAL
Intervention: Dietary intervention using the KELA.AE app
Number of subjects: 23
Study: 35107439

Group type: EXPERIMENTAL
Intervention: COPe-support (Carers fOr People with Psychosis e‐support), a psychoeducational intervention delivered via a web‐based platform for 8 months.
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: COPe-support
Number of subjects: 35
Study: 33222210

Group type: EXPERIMENTAL
Intervention: Metacognitive training group (N = 27)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (N = 29)
Number of subjects: 56
Study: 36171543

Group type: EXPERIMENTAL
Intervention: On-site trauma surgeon
Number of subjects: 58
Study: 33705179

Group type: EXPERIMENTAL
Intervention: Protecting Strong African American Families (ProSAAF) program
Number of subjects: 295

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: ProSAAF program
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Baseline racial discrimination
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Change in PPB
Number of subjects: 295
Study: 32848365

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C 1 g administered 10 minutes after induction of anesthesia, 10 minutes before cardiac reanimation, and at the moment of sternal closure
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C 1 g administered
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (saline injection)
Number of subjects: 70
Study: 32770782

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (routine FUE procedure)
Number of subjects: 34
Study: 35322777

Group type: EXPERIMENTAL
Intervention: Breast milk oral care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium bicarbonate solution for oral care
Number of subjects: 0
Study: 33730257

Group type: EXPERIMENTAL
Intervention: Probiotic baths with 4.5–9 × 10^9 CFU/liter
Number of subjects: 22
Study: 34971214

Group type: EXPERIMENTAL
Intervention: Active treatment (pulsed transcranial and intraocular 1068nm near-infrared light)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 100
Study: 32149424

Group type: EXPERIMENTAL
Intervention: 1.5 mg APT‐1011 BID
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 3.0 mg APT‐1011 QD
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 33713384

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (3 g)
Number of subjects: 437

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study: 33148357

Group type: EXPERIMENTAL
Intervention: Outlook intervention
Number of subjects: 135

Group type: COMPARATOR
Intervention: Relaxation meditation (RM)
Number of subjects: 135
Study: 37216189

Group type: EXPERIMENTAL
Intervention: Narrow-focus (2 mm) SWL
Number of subjects: 135

Group type: COMPARATOR
Intervention: Wide-focus (8 mm) SWL
Number of subjects: 135
Study: 32886237

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic gastrectomy (SLG)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Multi-port laparoscopic gastrectomy (MLG)
Number of subjects: 101
Study: 34238308

Group type: EXPERIMENTAL
Intervention: 300 mg/day NMN
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 600 mg/day NMN
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1200 mg/day NMN
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 32282603

Group type: EXPERIMENTAL
Intervention: Removal of double-balloon device after 6 hours
Number of subjects: 197

Group type: COMPARATOR
Intervention: Removal of double-balloon device after 12 hours
Number of subjects: 197
Study: 35609974

Group type: EXPERIMENTAL
Intervention: Coated flow diverter p64 MW HPC under single antiplatelet treatment (SAPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bare flow diverter p64 MW under dual antiplatelet treatment (DAPT)
Number of subjects: 0
Study: 34226917

Group type: EXPERIMENTAL
Intervention: Integrative machine learning framework called Enhancer-IF
Number of subjects: 8

Group type: COMPARATOR
Intervention: Baseline models using five commonly used ML methods
Number of subjects: 8
Study: 36100795

Group type: EXPERIMENTAL
Intervention: IV 400 mg ibuprofen
Number of subjects: 124

Group type: COMPARATOR
Intervention: IV 20 mg tenoxicam
Number of subjects: 124
Study: 34384882

Group type: COMPARATOR
Intervention: Continuous letrozole (2.5 mg/day for 5 years)
Number of subjects: 4884

Group type: EXPERIMENTAL
Intervention: Intermittent letrozole (2.5 mg/day for 9 months followed by a 3-month interruption in years 1-4 and then 2.5 mg/day during all of year 5)
Number of subjects: 4884

Group type: EXPERIMENTAL
Intervention: Both groups (Continuous and Intermittent letrozole)
Number of subjects: 4884

Group type: EXPERIMENTAL
Intervention: Intermittent letrozole
Number of subjects: 4884
Study: 35377717

Group type: EXPERIMENTAL
Intervention: Lenzilumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34599744

Group type: EXPERIMENTAL
Intervention: ART + Brix3000
Number of subjects: 20

Group type: COMPARATOR
Intervention: ART
Number of subjects: 20
Study: 34375362

Group type: EXPERIMENTAL
Intervention: EEG-guided anesthesia with sevoflurane adjusted to maintain a BIS index value between 40 and 60, Suppression Ratio (SR) at 0%, and direct EEG display without suppression time.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving sevoflurane to achieve an age-adjusted minimum alveolar concentration of [0.8-1.2].
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EEG-guided anesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32187503

Group type: EXPERIMENTAL
Intervention: 4D-calculated dose
Number of subjects: 20

Group type: COMPARATOR
Intervention: 3D plan
Number of subjects: 20
Study: 35644931

Group type: EXPERIMENTAL
Intervention: Tradipitant 85 mg b.i.d. for 9 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32353592

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 225

Group type: COMPARATOR
Intervention: High ligation and stripping (HLS)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Conservative hemodynamic cure for venous insufficiency (CHIVA)
Number of subjects: 225
Study: 32767636

Group type: EXPERIMENTAL
Intervention: CAD digital intervention platform
Number of subjects: 1856

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1856
Study: 36218354

Group type: EXPERIMENTAL
Intervention: Avdoralimab
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 33187948

Group type: EXPERIMENTAL
Intervention: 750 mg oral amoxicillin before and after surgery
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 750 mg oral amoxicillin after surgery alone
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo before and after surgery
Number of subjects: 92
Study: 35576560

Group type: EXPERIMENTAL
Intervention: Exercise group (patient education and exercise therapy using a mobile messaging app)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Conventional group (usual medical care with pharmacological treatment)
Number of subjects: 99
Study: 34378869

Group type: EXPERIMENTAL
Intervention: Sandplay therapy
Number of subjects: 60
Study: 35816140

Group type: EXPERIMENTAL
Intervention: 90% HRmax warm-up protocol
Number of subjects: 34

Group type: COMPARATOR
Intervention: 60% HRmax warm-up protocol
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: RSA performance with 90% HRmax
Number of subjects: 34

Group type: COMPARATOR
Intervention: RSA performance with 60% HRmax
Number of subjects: 34
Study: 33853796

Group type: EXPERIMENTAL
Intervention: Intervention arm (received additional consultations based on diabetes distress scores)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intervention arm
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control arm (standard care)
Number of subjects: 80
Study: 32289541

Group type: EXPERIMENTAL
Intervention: Internet-delivered education
Number of subjects: 296

Group type: COMPARATOR
Intervention: Face-to-face education
Number of subjects: 296
Study: 35114993

Group type: EXPERIMENTAL
Intervention: Osteoporotic fracture prevention program (OFRA) including falls prevention exercise classes, DXA scan, and safety consultation.
Number of subjects: 9408

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 9408
Study: 33864917

Group type: EXPERIMENTAL
Intervention: Oral hydroxychloroquine (400 mg once, followed by 200 mg/day)
Number of subjects: 3037

Group type: EXPERIMENTAL
Intervention: Povidone-iodine throat spray (3 times/day, 270 µg/day)
Number of subjects: 3037

Group type: COMPARATOR
Intervention: Oral zinc (80 mg/day)/vitamin C (500 mg/day) combination
Number of subjects: 3037

Group type: COMPARATOR
Intervention: Oral ivermectin (12 mg once)
Number of subjects: 3037

Group type: COMPARATOR
Intervention: Oral vitamin C (500 mg/day)
Number of subjects: 3037
Study: 35383545

Group type: EXPERIMENTAL
Intervention: Web-based intervention activating self-transcendence values
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 140
Study: 32862688

Group type: EXPERIMENTAL
Intervention: ATTUNE
Number of subjects: 74

Group type: COMPARATOR
Intervention: PFC-sigma
Number of subjects: 74
Study: 36209663

Group type: EXPERIMENTAL
Intervention: Higher environmental sensitivity group
Number of subjects: 503

Group type: COMPARATOR
Intervention: Low environmental sensitivity group
Number of subjects: 503
Study: 34417274

Group type: EXPERIMENTAL
Intervention: 7-day course of oral amoxicillin (according to WHO weight bands) provided by community level health workers (CLHWs) in intervention clusters.
Number of subjects: 2312

Group type: COMPARATOR
Intervention: Standard community case management (assess and refer after pre-referral antibiotic dose) in control clusters.
Number of subjects: 2312
Study: 32693740

Group type: EXPERIMENTAL
Intervention: T2D
Number of subjects: 20

Group type: COMPARATOR
Intervention: CON
Number of subjects: 20
Study: 35215507

Group type: EXPERIMENTAL
Intervention: Maternal hemoglobin concentration 100-110 g/L
Number of subjects: 3748

Group type: EXPERIMENTAL
Intervention: Maternal hemoglobin concentration <70 g/L
Number of subjects: 3748

Group type: EXPERIMENTAL
Intervention: Maternal hemoglobin concentration >130 g/L
Number of subjects: 3748

Group type: EXPERIMENTAL
Intervention: Maternal hemoglobin concentration <70 g/L or >130 g/L
Number of subjects: 3748